Review: Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy

Goyenvalle A, Davies KE. Challenges to oligonucleotides-based therapeutics for Duchenne musc... Skeletal Muscle. 2011;1:8 doi:10.1186/2044-5040-1-8

Views: 69

▶ Reply to This

Replies to This Discussion

Permalink Reply by Tulika on February 11, 2011 at 1:55pm

97% positive fiber from Pro051. Never saw these kind of numbers earlier.

 

Permalink Reply by Ofelia Marin on February 11, 2011 at 3:51pm
That's the IM study right? I have yet to see data from their Phase I/II systemic delivery trial. Those are the numbers we really want to see at this point, not sure why they don't make them public.

Tulika said:

97% positive fiber from Pro051. Never saw these kind of numbers earlier.

 

▶ Reply to Discussion

RSS

Need help using this community site? Visit Ning's Help Page.

Members

Events

Terms of Service

© 2020   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service